S. Chambers

1.7k total citations · 1 hit paper
18 papers, 1.1k citations indexed

About

S. Chambers is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, S. Chambers has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 4 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in S. Chambers's work include Systemic Lupus Erythematosus Research (9 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). S. Chambers is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). S. Chambers collaborates with scholars based in United Kingdom, United States and Denmark. S. Chambers's co-authors include W. G. Cochran, David Isenberg, Elizabeth Allen, A. Rahman, Anisur Rahman, Fiona Goldblatt, Guy H. Neild, Christopher Edwards, Rosalind Raine and Kanta Kumar and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

S. Chambers

16 papers receiving 1.1k citations

Hit Papers

The Planning of Observational Studies of Human Populations 1965 2026 1985 2005 1965 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Chambers United Kingdom 13 577 274 217 109 105 18 1.1k
Alexa Meara United States 15 591 1.0× 351 1.3× 17 0.1× 59 0.5× 70 0.7× 49 1.2k
Stacy P. Ardoin United States 23 599 1.0× 448 1.6× 13 0.1× 77 0.7× 107 1.0× 86 1.5k
Jeanna Welborn United States 17 109 0.2× 107 0.4× 31 0.1× 14 0.1× 120 1.1× 35 1.3k
Mia Djulbegovic United States 10 94 0.2× 54 0.2× 44 0.2× 85 0.8× 35 0.3× 21 1.5k
Jörg Mahlich Germany 21 173 0.3× 156 0.6× 30 0.1× 17 0.2× 69 0.7× 101 1.2k
Adrian Richter Germany 16 439 0.8× 166 0.6× 9 0.0× 33 0.3× 73 0.7× 46 841
Nikolaos P. Polyzos Belgium 47 48 0.1× 650 2.4× 29 0.1× 140 1.3× 177 1.7× 196 6.2k
Benjamin Kasenda Switzerland 25 44 0.1× 189 0.7× 84 0.4× 49 0.4× 570 5.4× 64 1.9k
Mohammad Movahedi Canada 15 259 0.4× 162 0.6× 9 0.0× 24 0.2× 59 0.6× 76 838
Ian Chalmers Canada 18 334 0.6× 316 1.2× 8 0.0× 23 0.2× 333 3.2× 46 1.3k

Countries citing papers authored by S. Chambers

Since Specialization
Citations

This map shows the geographic impact of S. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Chambers more than expected).

Fields of papers citing papers by S. Chambers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Chambers. The network helps show where S. Chambers may publish in the future.

Co-authorship network of co-authors of S. Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of S. Chambers. A scholar is included among the top collaborators of S. Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Chambers. S. Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Riaz, Nazia, Bingshu E. Chen, Anita Bane, et al.. (2025). Prognostic and predictive capacity of tumor infiltrating lymphocytes in the MA.20 regional node radiotherapy trial. npj Breast Cancer. 11(1). 97–97.
2.
Chambers, S., et al.. (2016). The sporting ankle. Orthopaedics and Trauma. 30(1). 24–29. 1 indexed citations
3.
Sprowson, Andrew P., Cyrus D. Jensen, S. Chambers, et al.. (2016). The use of high-dose dual-impregnated antibiotic-laden cement with hemiarthroplasty for the treatment of a fracture of the hip. The Bone & Joint Journal. 98-B(11). 1534–1541. 54 indexed citations
4.
Croca, Sara, Paul Bassett, S. Chambers, et al.. (2015). IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study. Arthritis Research & Therapy. 17(1). 26–26. 18 indexed citations
5.
Chambers, S., A. F. CLARKE, & Roger Wolman. (2011). Treatment of Lumbar Pars Interarticularis Stress Injuries in Athletes With Intravenous Bisphosphonates: Five Case Studies. Clinical Journal of Sport Medicine. 21(2). 141–143. 5 indexed citations
6.
Chambers, S., Elizabeth Allen, A. Rahman, & David Isenberg. (2009). Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Lara D. Veeken. 48(6). 673–675. 180 indexed citations
7.
Chambers, S., et al.. (2009). How much does international normalized ratio monitoring cost during oral anticoagulation with a vitamin K antagonist? A systematic review. International Journal of Laboratory Hematology. 32(4). 427–442. 19 indexed citations
8.
Kumar, Kanta, S. Chambers, & Caroline Gordon. (2009). Challenges of ethnicity in SLE. Best Practice & Research Clinical Rheumatology. 23(4). 549–561. 26 indexed citations
9.
Goldblatt, Fiona, et al.. (2009). Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus. 18(8). 682–689. 127 indexed citations
10.
Chambers, S., Rosalind Raine, Anisur Rahman, & David Isenberg. (2008). Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort. Lara D. Veeken. 48(3). 266–271. 65 indexed citations
11.
Chambers, S., et al.. (2008). Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica. Lupus. 17(8). 761–769. 47 indexed citations
13.
Chambers, S., Susan C. Charman, Anisur Rahman, & David Isenberg. (2007). Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality. Annals of the Rheumatic Diseases. 66(9). 1173–1177. 32 indexed citations
14.
Chambers, S., et al.. (2006). An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Lara D. Veeken. 45(9). 1144–1147. 127 indexed citations
15.
Hubbard, Robert L., et al.. (2003). A FEASIBILITY STUDY OF A TELEPHONE ENHANCEMENT PROCEDURE (TELE) TO IMPROVE PARTICIPATION IN CONTINUING CARE ACTIVITIES.
16.
Davis, Tania M., et al.. (2002). Women in addictions treatment: comparing VA and community samples. Journal of Substance Abuse Treatment. 23(1). 41–48. 21 indexed citations
17.
Hilton, David A., et al.. (1992). Demonstration of the distribution of Coxsackie virus RNA in neonatal mice by non-isotopic in situ hybridization. Journal of Virological Methods. 40(2). 155–162. 9 indexed citations
18.
Cochran, W. G. & S. Chambers. (1965). The Planning of Observational Studies of Human Populations. Journal of the Royal Statistical Society Series A (General). 128(2). 234–234. 369 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026